FDA Clears Candela's Matrix Radiofrequency Platform for Treatment of Facial Wrinkles

Source: Dermatology Times

Candela Corporation announced today that the US Food and Drug Administration (FDA) has cleared its Matrix multi-application radiofrequency skin platform for a new indication.

Read More